1600201

Regorafenib

United States Pharmacopeia (USP) Reference Standard

Manufacturer: Sigma Aldrich

CAS Number: 1019206-88-2

Synonym(S): Regorafenib monohydrate, 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide monohydrate

Select a Size

Pack Size SKU Availability Price
200 MG 1600201-200-MG In Stock ₹ 52,003.30

1600201 - 200 MG

₹ 52,003.30

In Stock

Quantity

1

Base Price: ₹ 52,003.30

GST (18%): ₹ 9,360.594

Total Price: ₹ 61,363.894

API family

regorafenib

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

15-25°C

InChI

1S/C21H15ClF4N4O3.H2O/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H2

InChI key

ZOPOQLDXFHBOIH-UHFFFAOYSA-N

Description

  • General description: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
  • Application: Regorafenib USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
  • Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
  • Other Notes: Sales restrictions may apply.

SAFETY INFORMATION

Pictograms

GHS08,GHS09

Signal Word

Warning

Hazard Statements

H361fd,H373,H410

Precautionary Statements

P202 - P260 - P273 - P280 - P308 + P313 - P391

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - STOT RE 2

Target Organs

Liver

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable